日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

UBE3A-mediated mH2A1 Ubiquitination activates TERT transcription to promote senescence resistance in pancreatic cancer

UBE3A介导的mH2A1泛素化激活TERT转录，从而促进胰腺癌的衰老抵抗。

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-026-08480-z
Ren, Likun; Lu, Rishang; Fei, Xiaobin; Chen, Shaojie; Liu, Peng; Liu, Songbai; Zhu, Changhao; Shen, Xiangchun; Wang, Xing; Pan, Yaozhen
UBE3A
肿瘤
表观遗传
肿瘤免疫
泛素化
衰老
胰腺癌
TERT
发表日期：2026
文献求助 收藏

PD-1/PD-L1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone as First-Line Therapy for Patients With Unfavorable Cancer of Unknown Primary: A Multicenter, Retrospective Cohort Study

PD-1/PD-L1抑制剂联合化疗与单纯化疗作为一线治疗原发灶不明且预后不良的癌症患者的疗效比较：一项多中心回顾性队列研究

期刊:MedComm
影响因子:10.7
doi:10.1002/mco2.70124
Huang, Riqing; Li, Haifeng; Li, Shuo; Shu, Ditian; Chen, Rishang; Zheng, Zhousan; Gao, Tinghua; Chen, Meiting; Hu, Anqi; Huang, Yunjie; Zheng, Qiufan; An, Xin; Xue, Cong; Cai, Yuchen; Shi, Yanxia
PD-L1
肿瘤
PD-1
肿瘤免疫
发表日期：2025
文献求助 收藏

Prognostic index for predicting outcomes of trastuzumab deruxtecan in HER2 expressing metastatic breast cancer: a real-world multicenter study

预测曲妥珠单抗德鲁替康治疗HER2阳性转移性乳腺癌疗效的预后指数：一项真实世界多中心研究

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyaf174
Xue, Cong; Liao, Qianyi; Huang, Riqing; Huang, Yunjie; Chen, Rishang; Yang, Zhenhua; Shen, Xiujiao; Li, Haifeng; Rong, Qixiang; Shu, Ditian; Pan, Fei; Shi, Yanxia; Chen, Meiting
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Clinical outcome and genomic biomarkers of immune checkpoint inhibitor-based therapies for cancer of unknown primary: a multicenter, real-world study

免疫检查点抑制剂疗法治疗原发灶不明癌症的临床结果和基因组生物标志物：一项多中心真实世界研究

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-025-06261-3
Huang, Yunjie; Huang, Riqing; Chen, Meiting; Zheng, Zhousan; Li, Haifeng; Chen, Rishang; Gao, Tinghua; Shu, Ditian; Hu, Anqi; Zheng, Qiufan; An, Xin; Shi, Yanxia; Xue, Cong
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

PELI1: key players in the oncogenic characteristics of pancreatic Cancer

PELI1：胰腺癌致癌特征的关键因素

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:11.4
doi:10.1186/s13046-024-03008-9
Xiaobin Fei #, Changhao Zhu #, Peng Liu, Songbai Liu, Likun Ren, Rishang Lu, Junyi Hou, Yongjia Gao, Xing Wang, Yaozhen Pan
代谢
肿瘤
胰腺癌
发表日期：2024
文献求助 收藏

TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, invasion, and metastasis of pancreatic cancer cells

TAGLN2靶向调控ARPC5介导的MEK/ERK信号通路激活影响胰腺癌细胞的增殖、侵袭和转移

期刊:Cellular Signalling
影响因子:4.4
doi:10.1016/j.cellsig.2024.111227
Yongjia Gao, Junyi Hou, Xiaobin Fei, Likun Ren, Rishang Lu, Peng Liu, Songbai Liu, Changhao Zhu, Xing Wang, Yaozhen Pan
代谢
信号转导
肿瘤
胰腺癌
肿瘤细胞
MAPK/ERK
发表日期：2024
文献求助 收藏

Optimal Sequential Strategies for Antibody-Drug Conjugate in Metastatic Breast Cancer: Evaluating Efficacy and Cross-Resistance

转移性乳腺癌抗体药物偶联物的最佳序贯治疗策略：疗效和交叉耐药性评估

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyae055
Chen, Meiting; Huang, Riqing; Chen, Rishang; Pan, Fei; Shen, Xiujiao; Li, Haifeng; Rong, Qixiang; An, Xin; Xue, Cong; Shi, Yanxia
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏